Inventiva IVA
NASDAQ IVA
$4.02 +0.07 (+1.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Inventiva (IVA) Other Non Operating Income (2020 - 2021)

Updated

Inventiva (IVA) posted Other Non Operating Income of -$573,904 for Q2 2025.

Analysis

Inventiva (IVA) Other Non Operating Income (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Inventiva 763.29 Mn 38.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 4.44 Mn
Mar 31, 2020 11,039.39
API Access

Inventiva Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IVA&period=max&api_key=YOUR_API_KEY